FI950697L - IL-4:n ja/tai IL-10:n uudet käytöt ja vasta-aineet niitä vastaan - Google Patents

IL-4:n ja/tai IL-10:n uudet käytöt ja vasta-aineet niitä vastaan Download PDF

Info

Publication number
FI950697L
FI950697L FI950697A FI950697A FI950697L FI 950697 L FI950697 L FI 950697L FI 950697 A FI950697 A FI 950697A FI 950697 A FI950697 A FI 950697A FI 950697 L FI950697 L FI 950697L
Authority
FI
Finland
Prior art keywords
antibodies against
novel uses
novel
antibodies
Prior art date
Application number
FI950697A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI950697A7 (fi
FI950697A0 (fi
Inventor
Robert Coffman
Vries Jan E De
Waal Malefyt Rene De
Fiona Powrie
Donna Rennick
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/932,900 external-priority patent/US5368854A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI950697A0 publication Critical patent/FI950697A0/fi
Publication of FI950697A7 publication Critical patent/FI950697A7/fi
Publication of FI950697L publication Critical patent/FI950697L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
FI950697A 1992-08-20 1993-08-18 IL-4:n ja/tai IL-10:n uudet käytöt ja vasta-aineet niitä vastaan FI950697L (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US07/932,900 US5368854A (en) 1992-08-20 1992-08-20 Use of IL-10 to treat inflammatory bowel disease
US93341992A 1992-08-21 1992-08-21
US93395092A 1992-08-21 1992-08-21
US93346292A 1992-08-21 1992-08-21
PCT/US1993/007646 WO1994004180A2 (en) 1992-08-20 1993-08-18 Novel uses of il-4 and/or il-10, and antibodies against the same

Publications (3)

Publication Number Publication Date
FI950697A0 FI950697A0 (fi) 1995-02-16
FI950697A7 FI950697A7 (fi) 1995-04-07
FI950697L true FI950697L (fi) 1995-04-07

Family

ID=27506019

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950697A FI950697L (fi) 1992-08-20 1993-08-18 IL-4:n ja/tai IL-10:n uudet käytöt ja vasta-aineet niitä vastaan

Country Status (22)

Country Link
EP (2) EP0671933B1 (OSRAM)
JP (1) JP3494647B2 (OSRAM)
KR (1) KR0170037B1 (OSRAM)
CN (1) CN1090204A (OSRAM)
AT (1) ATE162947T1 (OSRAM)
AU (1) AU680628B2 (OSRAM)
CA (1) CA2142861C (OSRAM)
CZ (1) CZ283488B6 (OSRAM)
DE (1) DE69316921T2 (OSRAM)
DK (1) DK0671933T3 (OSRAM)
ES (1) ES2111769T3 (OSRAM)
FI (1) FI950697L (OSRAM)
GR (1) GR3026635T3 (OSRAM)
HU (1) HU220103B (OSRAM)
IL (1) IL106725A (OSRAM)
MX (1) MX9305054A (OSRAM)
MY (1) MY111402A (OSRAM)
PL (1) PL307566A1 (OSRAM)
RU (1) RU2120802C1 (OSRAM)
SK (1) SK21195A3 (OSRAM)
TW (1) TW243415B (OSRAM)
WO (1) WO1994004180A2 (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017773A2 (en) * 1993-02-01 1994-08-18 Université Libre de Bruxelles Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
CZ1497A3 (en) * 1994-07-05 1997-05-14 Steeno Res Group As Polypeptide, its use and pharmaceutical composition based thereon, a nucleotide sequence and antibody
JPH11501506A (ja) 1994-12-12 1999-02-09 ベス イスラエル デアコネス メディカル センター キメラ型サイトカインおよびその利用
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
EP0756871A1 (en) * 1995-08-01 1997-02-05 Institut Pasteur Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
EP0901375A1 (en) * 1996-04-17 1999-03-17 Patrick Thomas Prendergast Dhea combination therapy
WO1998027997A1 (en) * 1996-12-20 1998-07-02 Magainin Pharmaceuticals Inc. A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis
AU5221998A (en) * 1997-04-17 1998-11-13 Patrick T. Prendergast Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6001651A (en) * 1998-03-20 1999-12-14 Isis Pharmaceuticals Inc. Antisense modulation of LFA-3
EP1123314B1 (en) * 1998-10-20 2004-02-18 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Use of a cytokine-producing lactococcus strain to treat colitis
RU2140283C1 (ru) * 1998-12-15 1999-10-27 Товарищество с ограниченной ответственностью "Биотех" Фармацевтический препарат на основе интерлейкина-2 (варианты)
MXPA01008142A (es) 1999-02-10 2003-07-21 Welfide Corp Compuestos de amida, y uso medicinal de los mismos.
JP2003518627A (ja) * 1999-12-03 2003-06-10 バクスター・インターナショナル・インコーポレイテッド 自動イムノアッセイシステムを用いる使用のための発熱性試験
KR20020091170A (ko) * 2000-03-31 2002-12-05 아이덱 파마슈티칼즈 코포레이션 Ｂ 세포 림프종의 치료를 위한 항-사이토카인 항체 또는길항제 및 항-ｃｄ２０의 조합된 사용
US6797263B2 (en) 2000-05-12 2004-09-28 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for achieving immune suppression
RU2196605C2 (ru) * 2000-12-07 2003-01-20 Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Способ получения растворимых конъюгатов биологически активных веществ
RU2202363C2 (ru) * 2001-04-09 2003-04-20 Ершов Феликс Иванович Способ определения чувствительности живого организма и/или его клеток к воздействию вещества, поля или комбинации веществ и/или полей
US20040197304A1 (en) * 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
US7261882B2 (en) * 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
PE20090047A1 (es) * 2003-11-10 2009-01-26 Schering Corp Anticuerpo recombinante humanizado anti-interleuquina 10
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
EP2270131A1 (en) 2005-05-31 2011-01-05 The Iams Company Feline probiotic lactobacilli
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
ES2399987T3 (es) * 2005-10-03 2013-04-04 Actogenix N.V. Uso de una cepa de levadura recombinante que produce un compuesto antiinflamatorio en la fabricación de un medicamento para tratar colitis
CA2664304C (en) * 2006-09-28 2017-08-22 Schering Corporation Use of pegylated il-10 to treat cancer
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
HK1215681A1 (zh) * 2013-04-18 2016-09-09 Armo Biosciences, Inc. 使用白细胞介素-10治疗疾病和病症的方法
US9823255B2 (en) 2013-06-17 2017-11-21 Armo Biosciences, Inc. Method for assessing protein identity and stability
RS57974B1 (sr) 2013-07-18 2019-01-31 Xalud Therapeutics Inc Sastavi za lečenje inflamatornog oboljenja zglobova
AU2014311432A1 (en) 2013-08-30 2016-03-03 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
ES3039640T3 (en) 2015-08-25 2025-10-23 Armo Biosciences Inc Methods of using interleukin-10 for treating diseases and disorders
CN114349858B (zh) * 2022-01-26 2022-07-01 优睿赛思(武汉)生物科技有限公司 抗人白介素-10高亲和力兔单克隆抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
DK0567576T3 (da) * 1991-01-16 1995-06-12 Schering Corp Behandling af neoplastiske sygdomme med interleukin-10
GB9207732D0 (en) * 1992-04-06 1992-05-27 Isis Innovation Wound repair

Also Published As

Publication number Publication date
AU680628B2 (en) 1997-08-07
JPH08500362A (ja) 1996-01-16
CA2142861A1 (en) 1994-03-03
CZ44195A3 (en) 1995-10-18
HU220103B (hu) 2001-10-28
DE69316921D1 (de) 1998-03-12
IL106725A (en) 2000-12-06
WO1994004180A3 (en) 1994-06-09
WO1994004180A2 (en) 1994-03-03
EP0671933A1 (en) 1995-09-20
IL106725A0 (en) 1993-12-08
JP3494647B2 (ja) 2004-02-09
FI950697A7 (fi) 1995-04-07
GR3026635T3 (en) 1998-07-31
FI950697A0 (fi) 1995-02-16
EP0801951A2 (en) 1997-10-22
ES2111769T3 (es) 1998-03-16
HUT70976A (en) 1995-11-28
CA2142861C (en) 2000-08-15
RU2120802C1 (ru) 1998-10-27
KR0170037B1 (ko) 1999-02-01
EP0801951A3 (en) 1998-05-20
PL307566A1 (en) 1995-05-29
CN1090204A (zh) 1994-08-03
HK1004326A1 (en) 1998-11-20
AU5010893A (en) 1994-03-15
SK21195A3 (en) 1996-10-02
KR950702841A (ko) 1995-08-23
EP0671933B1 (en) 1998-02-04
RU95108330A (ru) 1996-11-27
ATE162947T1 (de) 1998-02-15
DK0671933T3 (da) 1998-09-23
DE69316921T2 (de) 1998-06-04
MX9305054A (es) 1994-02-28
MY111402A (en) 2000-04-29
HU9500467D0 (en) 1995-04-28
CZ283488B6 (cs) 1998-04-15
TW243415B (OSRAM) 1995-03-21

Similar Documents

Publication Publication Date Title
FI950697L (fi) IL-4:n ja/tai IL-10:n uudet käytöt ja vasta-aineet niitä vastaan
ZA936060B (en) Novel uses of il-4 and/or il-10, and antibodies against the same
DE69317890D1 (de) Anbringbarer und wiederanbringbarer klebegegenstand
FI952853A7 (fi) Hankaamaton mekaaninen kiinnitysjärjestelmä ja sen valmistusmenetelmä
FI960718A7 (fi) Elastisia materiaaleja ja niistä valmistettuja tuotteita
FI961015L (fi) Nesteen ja kiinteiden aineosien erottaminen
BR9102840A (pt) Produto absorvente e metodo de fazer o mesmo
FI943345A7 (fi) Organo-aluminoksituotteet ja niiden käyttö
FI945625A7 (fi) Indolokarbatsoli-imidit ja niiden käyttö
FI940640L (fi) Organoaluminoksituotteet ja käyttö
BR9300289A (pt) Composicao de revestimento e artigo
FI935728A7 (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
FI943900A7 (fi) Muunnetusta zircaloysta koostuva materiaali ja rakenneosa
FI930076A7 (fi) Systeamiinia sisältävä permanenttauskoostumus ja menetelmä
BR9305947A (pt) Composição de vidro silico-soda-cálcico e vidraça
DE69332741D1 (de) Nachweis von hypoxia
DK0553389T3 (da) Småkage med højt indhold af korn
BR9305766A (pt) Composiçao aquosa de revestimento de autodeposiçao e revestimento de autodeposiçao
DE69328166D1 (de) Beseitigung von schmutzstoffen
BR9300291A (pt) Composicao de revestimento e artigo
DE69418193D1 (de) Sichere handhabung von tetrafluorethylen
DE69301529D1 (de) Methode zur Reduktion der Stoff- und Reibungsempfindlichkeit von Tetrazolen
FI944906A0 (fi) Uudet sykliset aminohapot ja niiden johdannaiset
DE69323391D1 (de) Personenaufempfänger mit Anzeige
BR9306359A (pt) Azocorantes aplicação do azocorante e modificação cristalina

Legal Events

Date Code Title Description
BB Publication of examined application
FD Application lapsed